SCHEMBL6578640

SCHEMBL6578640

CCOC(=O)c1ccc(C#Cc2ccc3c(c2)N(c2ccc(C)cc2)CCC3(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 12/20 0.49
RARA P10276 10/20 0.49
RARG P13631 9/20 0.49
CYP3A4 P08684 2/20 0.45
KMT2A Q03164 1/20 0.45
CYP26A1 O43174 1/20 0.42
CRABP2 P29373 1/20 0.42
MAPK1 P28482 1/20 0.40
MMP13 P45452 1/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 2/20 0.39
PRKCG P05129 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCA P17252 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCD Q05655 1/20 0.38
ALDH1A1 P00352 1/20 0.37
HSP90AA1 P07900 1/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8614817 0.92 RARB (0.52) RARBRARARARGCYP3A4KMT2A
SCHEMBL6578028 0.88 RARB (0.41) RARBRARARARGCYP3A4KMT2A
SCHEMBL6578025 0.87 RARB (0.65) RARBRARARARGCYP3A4CYP26A1
SCHEMBL6575692 0.82 MAPK1 (0.53) RARBRARARARGCYP3A4KMT2A
SCHEMBL9484975 0.79 RARB (0.67) RARBRARARARGCYP3A4KMT2A
SCHEMBL6574370 0.78 RARB (0.67) RARBRARARARGCYP3A4CYP26A1
SCHEMBL6576434 0.77 RARB (0.48) RARBRARARARGCYP3A4CYP26A1
SCHEMBL6575696 0.76 RARB (0.46) RARBRARARARGCYP3A4CYP26A1
SCHEMBL6575676 0.76 RARB (0.39) RARBRARARARGCYP3A4CYP26A1
SCHEMBL5737868 0.75 RARB (0.52) RARBRARARARGCYP3A4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed